Ozempic
- Other adverse reactions with a frequency of >0.4% were associated with Ozempic include fatigue, dysgeusia and dizziness.
Label revised Jun 1, 2026. DailyMed
Fatigue is in the main trial table of 5 labels. The highest rate printed is 11% on Wegovy 2.4 mg (5% on placebo) and the lowest 5.6% on Trulicity 1.5 mg (2.6% on placebo). Separate trials, so not a ranking.
Read from each manufacturer's FDA label on DailyMed. The newest revision saying anything on this is Aug 27, 2026.
At the highest dose in each label's main table. Separate trials with different people, so compare each rate with its own placebo group, not with another medicine.
Sentences from each label's warnings and side effect sections. Only cross-references are removed.
Label revised Jun 1, 2026. DailyMed
Label revised Aug 27, 2026. DailyMed
Label revised Feb 25, 2026. DailyMed
Wegovy, Rybelsus and Ozempic tablets, Zepbound, Foundayo, Trulicity, Victoza, Byetta: no finding on this in the sections read here.
Counts of voluntary reports from patients and doctors. They cannot show that a medicine caused anything and cannot give a rate, and a brand used by more people draws more reports.
| Medicine | Reports naming | All reports on it |
|---|---|---|
| Zepbound | Fatigue: 2,973 · Weakness: 851 | 80,835 |
| Ozempic | Fatigue: 2,967 · Weakness: 1,864 | 70,863 |
| Mounjaro | Fatigue: 2,597 · Weakness: 1,060 | 97,440 |
| Trulicity | Fatigue: 2,421 · Weakness: 1,299 | 87,279 |
| Byetta | Fatigue: 1,762 · Weakness: 1,545 | 52,087 |
| Victoza | Fatigue: 1,305 · Weakness: 851 | 41,462 |
| Wegovy | Fatigue: 1,116 · Weakness: 385 | 25,993 |
| Saxenda | Fatigue: 325 · Weakness: 125 | 7,270 |
| Rybelsus and Ozempic tablets | Fatigue: 313 · Weakness: 242 | 7,758 |
| Foundayo | Fatigue: 226 · Weakness: 52 | 3,050 |
Counted through openFDA from FDA's Adverse Event Reporting System, refreshed weekly. One report can name several terms.
Written from each source's own record as it changes. Every change on GLPcompare
No trial here ranks them. By the rates each label prints, Wegovy 2.4 mg is highest at 11% (placebo 5%) and Trulicity 1.5 mg lowest at 5.6% (placebo 2.6%). These come from separate trials with different people and doses, so compare each to its own placebo group.
In its FDA label, 11% of people taking Wegovy 2.4 mg reported fatigue, against 5% on placebo.
In its FDA label, 9% of people taking Foundayo 17.2 mg reported fatigue, against 4% on placebo.
In its FDA label, 7.5% of people taking Saxenda 3 mg reported fatigue, against 4.6% on placebo.
In its FDA label, 7% of people taking Zepbound 15 mg reported fatigue, against 3% on placebo.
In its FDA label, 5.6% of people taking Trulicity 1.5 mg reported fatigue, against 2.6% on placebo.
Labels describe when it happens, not how many days it lasts. Saxenda: "Events of asthenia, fatigue, malaise, dysgeusia and dizziness were mainly reported within the first 12 weeks of treatment with Saxenda and were often co-reported with gastrointestinal events such as nausea, vomiting, and diarrhea."
Trial rates describe groups, not what one person will feel. Talk to your clinician before starting, stopping or changing a medicine.